Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDSilexion Therapeutics Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$3.30 | -$3.30 | -$3.30 |
| Q2 2025 | 1 | -$3.15 | -$3.15 | -$3.15 |
| Q3 2025 | 1 | -$3.40 | -$3.40 | -$3.40 |
| Q4 2025 | 1 | -$1.07 | -$1.07 | -$1.07 |
Silexion Therapeutics Ltd. Earnings Date And Information
Silexion Therapeutics Ltd. last posted its earnings results on Wednesday, November 12th, 2025. The company reported $-2.88 earnings per share for the quarter, topping analysts' consensus estimates of $-3.4 by $0.52. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Silexion Therapeutics Ltd. has generated $-3 earnings per share over the last year ($-2.64 diluted earnings per share) and currently has a price-to-earnings ratio of -0.1. Silexion Therapeutics Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 24th, 2026 based on prior year's report dates.
Silexion Therapeutics Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2025 | Q3 2025 | -$3.40 | $2.88 | 6.28 | $0 | $0 |
| 08/12/2025 | Q2 2025 | -$3.15 | $4.32 | 7.47 | $0 | $0 |
| 05/13/2025 | Q1 2025 | -$0.22 | -$0.26 | -0.04 | $0 | $0 |
| 03/18/2025 | Q4 2024 | -$0.98 | -$0.19 | 0.79 | $0 | $0 |
| 11/14/2024 | Q3 2024 | -$7.38 | -$1.15 | 6.23 | $0 | $0 |
| 08/29/2024 | Q2 2024 | N/A | -$0.03 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$1.27 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | N/A | -$1.78 | N/A | N/A | $0 |
| 09/30/2023 | Q3 2023 | N/A | $0.01 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | $0.02 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | N/A | $0.03 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | $0.03 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | $0.02 | N/A | N/A | $0 |
| 06/29/2022 | Q2 2022 | N/A | $0.00 | N/A | N/A | $0 |
| 03/30/2022 | Q1 2022 | N/A | -$0.01 | N/A | N/A | $0 |
| 12/30/2021 | Q4 2021 | N/A | -$0.01 | N/A | N/A | $0 |
| 09/29/2021 | Q3 2021 | N/A | -$0.01 | N/A | N/A | $0 |
| 06/29/2021 | Q2 2021 | N/A | -$0.01 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$0.01 | N/A | N/A | $0 |
| 12/30/2020 | Q4 2020 | N/A | -$0.01 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Silexion Therapeutics Ltd. Earnings: FAQ's
Silexion Therapeutics Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 24th, 2026 based offlast year's report dates.
In the previous quarter, Silexion Therapeutics Ltd. (:SLXN) reported $-2.88 earnings per share (EPS) to beat the analysts' consensus estimate of $-3.4 by $0.52.
The conference call for Silexion Therapeutics Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Silexion Therapeutics Ltd.'s latest earnings report can be read online.
Silexion Therapeutics Ltd. (:SLXN) has a recorded net income of $-16,443,000.Silexion Therapeutics Ltd. has generated $-2.64 earnings per share over the last four quarters.
Silexion Therapeutics Ltd. (:SLXN) has a price-to-earnings ratio of -0.1 and price/earnings-to-growth ratio is -0.